IPR, innovation, human rights and access to drugs
Material type:
TextSeries: Health, Economics and Drugs, EDM (Essential Drugs and Medicines) Series No.14Publication details: Geneva World Health Organisation 2003Edition: 3rd edDescription: 79pSubject(s): LOC classification: - QV 736 .W46 2003
| Item type | Current library | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|
Book
|
AMREF INTERNATIONAL UNIVERSITY (AMIU) LIBRARY | QV 736 .W46 2003 (Browse shelf(Opens below)) | Available |
Browsing AMREF INTERNATIONAL UNIVERSITY (AMIU) LIBRARY shelves Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | |||||||
| QV 717 .A95 2013 Aulton's pharmaceutics the: design and manufacture of medicines | QV 735 .G8 Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies | QV 736 .M3 Managing drug supply: the selection, procurement, distribution and use of pharmaceuticals | QV 736 .W46 2003 IPR, innovation, human rights and access to drugs | QV 737 .D66 1998 | QV 737 .D8 Guide to drug financing mechanisms | QV 737 .D66 1998|QV 737 .D8 Guide to drug financing mechanisms | QV 737 .R88 2013 Community pharmacology: symptoms, diagnosis and treatment |
Issues of globalisation, patents and drugs are discussed in this book with focus on existing opportunities to adapt to ever changing realities in developing countries. It contains discussions on the World Trade Organisation’s trade-related aspects of intellectual property rights, patents, research and development and human rights, and access to drugs. The discussions are discussed drawing examples and experiences from different countries which take into consideration the domestic implications and effects.
There are no comments on this title.